Press-release for stocks for VNDA

Prices are updated after-hours

Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
Published: 2024-01-30 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M

| 37.89% | O: 0.0% H: 0.26% C: -3.95%
fda resolve

Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 00:00) - biospace.com/
VNDA | $4.97 -5.15% -5.43% 3.9M

| -18.38% | O: -0.16% H: 0.7% C: -0.31%
pharmaceuticals financial results

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023
Published: 2023-02-01 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M

| -31.68% | O: 1.04% H: 2.84% C: 1.03%
pharmaceuticals year financial results

Vanda Pharmaceuticals Announces Presentations at DDW 2022
Published: 2022-05-19 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M

| -46.96% | O: 0.71% H: 1.81% C: -0.3%

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
Published: 2022-02-17 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M

| -61.13% | O: -1.26% H: 1.73% C: 0.75%
als financial results results

Vanda Pharmaceuticals Announces Participation at November 2021 Investor Conferences
Published: 2021-11-10 (Crawled : 00:00) - prnewswire.com
VNDA | $4.97 -5.15% -5.43% 3.9M

| -70.97% | O: -1.39% H: 2.64% C: 1.97%
conference

64%

36%

AGBA | News | $1.02 155.0% 57.94% 120M

ZCMD | $2.86 108.76% 52.1% 2.3M

INVO | $1.555 104.6% 51.13% 5M

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M

GGE | $0.035 19.86% 29.3% 64M

Save your searches and get alerts when important news are released.